Clearside Biomedical (CLSD) Competitors $0.95 -0.08 (-7.77%) Closing price 04:00 PM EasternExtended Trading$0.98 +0.03 (+2.74%) As of 07:04 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends CLSD vs. CRVS, TRVI, CMPS, AQST, GOSS, CADL, ATYR, IMMP, OLMA, and KRROShould you be buying Clearside Biomedical stock or one of its competitors? The main competitors of Clearside Biomedical include Corvus Pharmaceuticals (CRVS), Trevi Therapeutics (TRVI), COMPASS Pathways (CMPS), Aquestive Therapeutics (AQST), Gossamer Bio (GOSS), Candel Therapeutics (CADL), Atyr PHARMA (ATYR), Immutep (IMMP), Olema Pharmaceuticals (OLMA), and Korro Bio (KRRO). These companies are all part of the "pharmaceutical products" industry. Clearside Biomedical vs. Corvus Pharmaceuticals Trevi Therapeutics COMPASS Pathways Aquestive Therapeutics Gossamer Bio Candel Therapeutics Atyr PHARMA Immutep Olema Pharmaceuticals Korro Bio Clearside Biomedical (NASDAQ:CLSD) and Corvus Pharmaceuticals (NASDAQ:CRVS) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, risk, media sentiment, community ranking, institutional ownership, earnings, valuation and profitability. Does the media refer more to CLSD or CRVS? In the previous week, Clearside Biomedical had 3 more articles in the media than Corvus Pharmaceuticals. MarketBeat recorded 4 mentions for Clearside Biomedical and 1 mentions for Corvus Pharmaceuticals. Clearside Biomedical's average media sentiment score of 0.82 beat Corvus Pharmaceuticals' score of 0.00 indicating that Clearside Biomedical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Clearside Biomedical 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Corvus Pharmaceuticals 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is CLSD or CRVS more profitable? Corvus Pharmaceuticals has a net margin of 0.00% compared to Clearside Biomedical's net margin of -413.83%. Clearside Biomedical's return on equity of 0.00% beat Corvus Pharmaceuticals' return on equity.Company Net Margins Return on Equity Return on Assets Clearside Biomedical-413.83% N/A -92.90% Corvus Pharmaceuticals N/A -70.71%-45.90% Which has better valuation & earnings, CLSD or CRVS? Corvus Pharmaceuticals has lower revenue, but higher earnings than Clearside Biomedical. Corvus Pharmaceuticals is trading at a lower price-to-earnings ratio than Clearside Biomedical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioClearside Biomedical$8.23M8.75-$32.49M-$0.45-2.11Corvus PharmaceuticalsN/AN/A-$27.03M-$0.93-4.51 Which has more risk & volatility, CLSD or CRVS? Clearside Biomedical has a beta of 2.22, meaning that its stock price is 122% more volatile than the S&P 500. Comparatively, Corvus Pharmaceuticals has a beta of 1.07, meaning that its stock price is 7% more volatile than the S&P 500. Do analysts recommend CLSD or CRVS? Clearside Biomedical presently has a consensus target price of $5.33, suggesting a potential upside of 461.40%. Corvus Pharmaceuticals has a consensus target price of $12.38, suggesting a potential upside of 195.35%. Given Clearside Biomedical's higher possible upside, equities analysts plainly believe Clearside Biomedical is more favorable than Corvus Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Clearside Biomedical 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00Corvus Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 3.20 Does the MarketBeat Community favor CLSD or CRVS? Clearside Biomedical received 77 more outperform votes than Corvus Pharmaceuticals when rated by MarketBeat users. Likewise, 67.28% of users gave Clearside Biomedical an outperform vote while only 61.91% of users gave Corvus Pharmaceuticals an outperform vote. CompanyUnderperformOutperformClearside BiomedicalOutperform Votes36867.28% Underperform Votes17932.72% Corvus PharmaceuticalsOutperform Votes29161.91% Underperform Votes17938.09% Do institutionals & insiders hold more shares of CLSD or CRVS? 18.8% of Clearside Biomedical shares are owned by institutional investors. Comparatively, 46.6% of Corvus Pharmaceuticals shares are owned by institutional investors. 9.2% of Clearside Biomedical shares are owned by insiders. Comparatively, 31.3% of Corvus Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryClearside Biomedical beats Corvus Pharmaceuticals on 11 of the 18 factors compared between the two stocks. Get Clearside Biomedical News Delivered to You Automatically Sign up to receive the latest news and ratings for CLSD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CLSD vs. The Competition Export to ExcelMetricClearside BiomedicalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$72.05M$7.04B$5.78B$8.98BDividend YieldN/A2.87%4.78%3.85%P/E Ratio-2.116.1326.4618.82Price / Sales8.75313.78457.6880.73Price / CashN/A67.8344.0437.47Price / Book-3.806.747.634.64Net Income-$32.49M$138.11M$3.18B$245.69M7 Day Performance-11.21%-2.02%-1.82%-2.63%1 Month Performance3.03%-1.54%0.22%-2.37%1 Year Performance-26.92%-3.14%17.49%13.65% Clearside Biomedical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CLSDClearside Biomedical2.0903 of 5 stars$0.95-7.8%$5.33+461.4%-20.2%$72.05M$8.23M-2.1130CRVSCorvus Pharmaceuticals1.9065 of 5 stars$4.88-0.8%$12.38+153.6%+90.1%$313.59MN/A-5.2530News CoverageTRVITrevi Therapeutics2.7475 of 5 stars$4.07+1.5%$9.31+128.8%+75.2%$312.86MN/A-9.2520News CoveragePositive NewsGap UpCMPSCOMPASS Pathways1.7049 of 5 stars$4.57+3.4%$30.60+569.6%-55.4%$312.68MN/A-2.08120AQSTAquestive Therapeutics2.1578 of 5 stars$3.32-4.3%$11.00+231.3%+16.0%$302.72M$50.58M-7.38160Short Interest ↓GOSSGossamer Bio3.9701 of 5 stars$1.31flat$9.20+602.3%+21.4%$296.85MN/A-4.09180High Trading VolumeCADLCandel Therapeutics3.5635 of 5 stars$9.05+2.6%$17.00+87.8%+609.9%$293.91M$120,000.00-5.2360Analyst ForecastNews CoverageATYRAtyr PHARMA2.8132 of 5 stars$3.41-5.0%$19.25+464.5%N/A$286.24M$350,000.00-3.6353Analyst ForecastAnalyst RevisionNews CoverageGap UpIMMPImmutep0.9724 of 5 stars$1.96+0.5%$8.50+333.7%-11.7%$285.30M$5.14M0.002,021Upcoming EarningsOLMAOlema Pharmaceuticals3.2661 of 5 stars$4.97+2.9%$28.75+478.5%-64.6%$284.78MN/A-2.2770KRROKorro Bio0.9188 of 5 stars$30.02+3.2%$144.00+379.7%-48.8%$281.29MN/A0.0070News CoverageGap Up Related Companies and Tools Related Companies Corvus Pharmaceuticals Competitors Trevi Therapeutics Competitors COMPASS Pathways Competitors Aquestive Therapeutics Competitors Gossamer Bio Competitors Candel Therapeutics Competitors Atyr PHARMA Competitors Immutep Competitors Olema Pharmaceuticals Competitors Korro Bio Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:CLSD) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredElon “obliterates” Bill Gates?All 10 of the world's biggest money managers follow my work, and the Pentagon, the FBI and Harvard professors ...Altimetry | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | SponsoredBetter than Bitcoin – and potentially more profitableThe world is obsessed with Bitcoin again... And for a good reason: It just soared beyond $100,000. Bitcoin ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Clearside Biomedical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Clearside Biomedical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
